| Address: | 750 US-202, Bridgewater, NJ 08807, USA |
|---|---|
| Postal code: | 08807 |
| Phone: | (908) 800-7140 |
| Website: | http://www.pbiorx.com/contact.html |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Princeton BioPharma, use the form below and your opinion, advice or comment will appear in this space.
Princeton BioPharma is actively seeking partnerships with pharmaceutical companies to expand our portfolio. BY MAIL Princeton BioPharma, LLC. 750 Route 202 Suite 620 Bridgewater, NJ 08807. Phone: 908-800-7140. If you are seeking growth capital for a private health care company please...
At Princeton Biopharma Capital Partners, we can leverage our capital and operating experience to work with management teams to unlock value At Princeton Biopharma Capital Partners, we look to work with existing companies that need growth capital or with proven operators to help them grow.
Princeton Biopharma Capital Partners provides financial and intellectual capital to commercial-stage healthcare companies with products with growth potential that make a significant impact on patients' lives.
Princeton Biopharma Capital Partners, LLC is a private equity investment firm focused on investing in commercial stage healthcare companies. Our target investments include start-ups being formed around carve-outs and existing companies in need of growth capital or restructuring.
908. Investors Active in Greater Philadelphia Area.
Princeton Biopharma Capital Partners, LLC is a private equity investment firm focused on pharmaceutical companies and products with the potential to grow while improving the lives of patients with significant medical needs. Chief Financial Officer.
Princeton Biopharma Capital Partners is a private equity investment firm focused on investing in commercial stage healthcare companies. 750 Route 202 Suite 620 Bridgewater, 8807 New Jersey, United States. Princeton BioPharma Capital Partners - Investments & Acquisitions.
Managing Director, Princeton Biopharma. Dean Mitchell is the Chairman of the Board of Covis Pharma Holdings ‐ the parent company of Covis Michael is a Managing Director at Princeton Biopharma Capital Partners, LLC a boutique private equity firm focused on providing growth capital...
Princeton BioPharma. Princeton BioPharma. 13 Jul 201713 Jul 2017. in.
He founded Princeton Biopharma Capital Partners, LLC is a private equity firm. Prior to Princeton Biopharma, he was the founder and CEO of Aton Pharma, Inc., acquired by Valeant Pharmaceuticals for $330 million. He was a recipient of the Ernst & Young Entrepreneur of the Year Award in 2009.